The significant decrease in COX-2 levels observed in this study suggests that SETL may attenuate the inflammatory response in neurodegenerative diseases, providing another mechanism by which it could protect against neurotoxicity. The gene discussed is PTGS2; the disease is neurodegenerative disease.